Ann V Burgess

Title: **Innovative Contributions of Ann V Burgess in Bone Grafting Technology**

Introduction

Ann V Burgess, an accomplished inventor based in Cordova, TN, has made significant contributions to the field of biomedical engineering through her innovative work on synthetic bone graft substitutes. With two patents to her name, her inventions are poised to advance the capabilities of bone grafting procedures, offering new hope for patients requiring surgical interventions.

Latest Patents

Ann's most notable patents focus on a synthetic malleable bone graft substitute material. The first patent describes an innovative synthetic bone substitute material that serves as a suitable replacement for cancellous bone in bone graft compositions. This material features a reticulated framework composed of interconnecting bioceramic struts, which defines an interconnecting interstitial void volume. These structures allow for a solid non-porous composition to fill the void volume, ensuring optimal contact with the framework. The pore-filling composition consists primarily of calcium sulfate, with calcium triphosphate identified as a preferred bioceramic material for the reticulated framework.

The second patent also revolves around a similar synthetic bone substitute material, reinforcing the potential applications of her work in enhancing the performance and integration of bone grafts in surgical procedures.

Career Highlights

Ann V Burgess works at Wright Medical Technology, Inc., a leading company in the development of innovative medical devices and implants. Her role in the company has allowed her to push the boundaries of technology in orthopedic solutions, particularly in synthetic bone grafting.

Collaborations

Throughout her career, Ann has collaborated with notable colleagues, including Robyn J Overby and Olaf H Schulz. These collaborations have helped strengthen her innovations and contribute to advancements in medical technologies.

Conclusion

Ann V Burgess continues to be a prominent figure in the field of biomedical innovation, with her patents for synthetic bone graft substitutes demonstrating both her creativity and the potential for improved patient outcomes in orthopedic surgeries. Her work contributes to a growing body of knowledge that aims to enhance the effectiveness of bone grafting, ultimately benefiting the medical community and patients alike.